About
Atara Biotherapeutics Inc (NASDAQ:ATRA) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 16 2026
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress
Mar 3 2026
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
Feb 23 2026
Atara Biotherapeutics Provides a Business Update
Jan 12 2026
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
Nov 12 2025
Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress
Financials
Revenue
$120.77 M
Market Cap
$39.83 M
P/E Ratio
1.89
EPS
2.57
Translate